Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Erika Heninger"'
Autor:
Wei Huang, Brian Johnson, Jamie Sperger, Erika Heninger, David Jarrard, Joshua Lang, Irene Ong, Steve Cho, Peter Geiger, Sheena Kerr, Kristin Weinstein, Shane Wells, Philippos Tsourkas, Sean J Mcilwain, David Beebe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f473602fac1d46a5b8fdc6907a4757c2
Autor:
Tamara S. Rodems, Erika Heninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison R. Kircher, Anupama Singh, Timothy E. G. Krueger, David J. Beebe, David F. Jarrard, Douglas G. McNeel, Michael C. Haffner, Joshua M. Lang
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-16 (2022)
Loss of HLA-I gene expression in prostate cancer is associated with repressive chromatin states, which can be reversed by pharmacological DNMT and HDAC inhibition leading to increased activation of co-cultured tumor-specific CD8+ T-cells.
Externí odkaz:
https://doaj.org/article/1153e9cc0b6a481e85909d4a3f28af7d
Autor:
Rory M. Bade, Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino, Joshua A. Desotelle, Erika Heninger, Charlotte N. Stahlfeld, Jamie M. Sperger, Anupama Singh, Serena K. Wolfe, David J. Niles, Waddah Arafat, John A. Steinharter, E. Jason Abel, David J. Beebe, Xiao X. Wei, Rana R. McKay, Toni K. Choueri, Joshua M. Lang
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2330-2344 (2021)
Although therapeutic options for patients with advanced renal cell carcinoma (RCC) have increased in the past decade, no biomarkers are yet available for patient stratification or evaluation of therapy resistance. Given the dynamic and heterogeneous
Externí odkaz:
https://doaj.org/article/e1c2e50d818746e18a79e0890de7a105
Autor:
Nan Sethakorn, Erika Heninger, Cristina Sánchez-de-Diego, Adeline B. Ding, Ravi Chandra Yada, Sheena C. Kerr, David Kosoff, David J. Beebe, Joshua M. Lang
Publikováno v:
Cancers, Vol 14, Iss 3, p 757 (2022)
Bone metastases represent a lethal condition that frequently occurs in solid tumors such as prostate, breast, lung, and renal cell carcinomas, and increase the risk of skeletal-related events (SREs) including pain, pathologic fractures, and spinal co
Externí odkaz:
https://doaj.org/article/2a2b2c67ae964046b2f3b66e12a1b56b
Autor:
Jennifer L Schehr, Zachery D Schultz, Jay W Warrick, David J Guckenberger, Hannah M Pezzi, Jamie M Sperger, Erika Heninger, Anwaar Saeed, Ticiana Leal, Kara Mattox, Anne M Traynor, Toby C Campbell, Scott M Berry, David J Beebe, Joshua M Lang
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159397 (2016)
Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to
Externí odkaz:
https://doaj.org/article/8f6661b01ec84d04955efc3f9136e5d9
Publikováno v:
Journal of Skin Cancer, Vol 2013 (2013)
To find clues about the mechanism by which kinase C epsilon (PKCε) may impart susceptibility to ultraviolet radiation (UVR)-induced development of cutaneous squamous cell carcinomas (SCC), we compared PKCε transgenic (TG) mice and their wild-type (
Externí odkaz:
https://doaj.org/article/2c2c2b20f86d461681e1e518d9837384
Publikováno v:
PLoS Pathogens, Vol 8, Iss 7, p e1002771 (2012)
Vaccines may help reduce the growing incidence of fungal infections in immune-suppressed patients. We have found that, even in the absence of CD4(+) T-cell help, vaccine-induced CD8(+) T cells persist and confer resistance against Blastomyces dermati
Externí odkaz:
https://doaj.org/article/1c270bec882643da9c8c680ff6e05a06
Autor:
Stephane Esnault, Ruedi K Braun, Zhong-Jian Shen, Zhuzai Xiang, Erika Heninger, Robert B Love, Matyas Sandor, James S Malter
Publikováno v:
PLoS ONE, Vol 2, Iss 2, p e226 (2007)
BACKGROUND/ABSTRACT: Immune responses initiated by T cell receptor (TCR) and costimulatory molecule mediated signaling culminate in maximal cytokine mRNA production and stability. The transcriptional responses to co-stimulatory T cell signalling invo
Externí odkaz:
https://doaj.org/article/a98a56fa8d6644c5a701cc037416a9d1
Autor:
Jamie M. Sperger, Kyle T. Helzer, Charlotte N. Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R. Kaufmann, David J. Niles, Erika Heninger, Nicholas R. Rydzewski, Liguo Wang, Liewei Wang, Rendong Yang, Yanan Ren, Jonathan W. Engle, Peng Huang, Christos E. Kyriakopoulos, Susan F. Slovin, Howard R. Soule, Shuang G. Zhao, Manish Kohli, Scott T. Tagawa, Weibo Cai, Scott M. Dehm, Joshua M. Lang
Publikováno v:
Clinical Cancer Research. :OF1-OF12
Purpose: Men with metastatic castration-resistant prostate cancer (mCRPC) frequently develop resistance to androgen receptor signaling inhibitor (ARSI) treatment; therefore, new therapies are needed. Trophoblastic cell-surface antigen (TROP-2) is a t
Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
Autor:
Joshua M. Lang, Scott M. Dehm, Weibo Cai, Scott T. Tagawa, Manish Kohli, Shuang G. Zhao, Howard R. Soule, Susan F. Slovin, Christos E. Kyriakopoulos, Peng Huang, Jonathan W. Engle, Yanan Ren, Rendong Yang, Liewei Wang, Liguo Wang, Nicholas R. Rydzewski, Erika Heninger, David J. Niles, Katherine R. Kaufmann, Anupama Singh, Dawei Jiang, Charlotte N. Stahlfeld, Kyle T. Helzer, Jamie M. Sperger
Figure S1. Correlation of TACSTD2 with Prostate Cancer Cell Surface Markers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0364775d8422639e4ff292c0b654309b
https://doi.org/10.1158/1078-0432.22709374.v1
https://doi.org/10.1158/1078-0432.22709374.v1